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Abstract 
We have previously studied and compared the location of (-)-AS-tetrahydrocannabinol (AS-THC) with that of O-methyl-AS-THC 
(Me-AS-THC) in the membrane using partially hydrated imyristoylphosphatidylcholine (DMPC) bilayers ((Mavromoustakos et al. (1990) 
Biophys. Acta 1024, 336-344; Yang et al. (1993) Life Sci. 53, 117-122). A~-THC was found to be located near the membrane interface 
with its phenolic hydroxyl group anchored near the carbonyl groups of DMPC while the more lipophilic Me-,.IS-THC is located deeper in 
the membrane bilayer. Parallel experiments using Me-A~-THC and its 5'-iodo analog (5'-I-Me-AS-THC) allowed us to determine the 
topography of these two molecules in the bilayer. Out results from small angle X-ray diffraction and differential scanning calorimetry 
(DSC) combined with previous data on the orientation of Me-AX-THC in model membranes, led us to the conclusion that these molecules 
intercalate between contiguous acyl chains in the lipophilic moiety of the membrane bilayer. The terminal iodo group in 5'-I-Me-JS-THC 
was found to reside in a region extending approx. + 5 A from the center of the bilayers. The location of Me-AS-THC in the membranes as 
well as its orientation may explain its inability to effectively petlurb the bilayer lipid chains. 
Keyn'ords: Small angle X-ray diffraction: DSC; Drug-membrane interaction: Cannabinoid: (-)-O-Methyl-3S-tetrahydrocannabinoh 5'q do-O-methyl- 
d S-tetrahydrocannabinol 
1. Introduction 
It is well known that the phenolic hydroxyl group of a 
cannabinoid is a strict requirement for cannabimimetic 
activity [1] and methylation of this group to give the 
O-methyl ether results in an analog devoid of biological 
activity [2]. 
Earlier work [3-5] compared the effects of a pharmaco- 
logically active cannabinoid possessing a phenolic hy- 
droxyl group (,.4~-THC) with its inactive O-methyl analog 
(Me-A~-THC) (Fig. 1). In these studies we showed, using 
DSC and solid state 2H-NMR. that the phenolic -OH in 
Abbreviations: DSC, differential scanning calorimetry; DMPC, 
dimyristoylphosphatidylcholine; RH. relative humidity; AS-THC, ( - ) -  
3~-tetrahydrocannabinol; Me-A~-THC, O-methyI-A~-tetrahydrocanna - 
binol; 5'-I-Me-A~-THC, 5'-iodo-O-methyl-AS-tetrahydrocannabinol. 
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4S-THC allows it to interact with the membrane at the 
bilayer interface, while Me-A~-THC fails to do so. Solid 
state 2H-NMR data have also shown that Aa-THC orients 
with the long axis of its tricyclic structure perpendicular to
the bilayer chains. Conversely, Me-AS-THC was shown to 
assume an orientation in which the long axis of the tri- 
cyclic structure, is parallel to the lipid chains [6]. 
In a previous publication, small-angle X-ray diffraction 
was used to determine the location of JS-THC in partially 
hydrated DMPC bilayers [7]. The work, which involved 
the use of AS-THC and its 5'-iodo analog in parallel 
experiments, allowed us to determine the location of the 
iodine atom in the bilayer. Based on these results and 
previous data on the orientation of the cannabinoid in 
model membranes, we concluded that the phenolic hy- 
droxyl of the drug molecule is located near the carbonyl 
groups of DMPC and the average position of the iodine 
atom is approx. 5.5 ,~ from the center of the DMPC 
bilayer (terminal methyl region). This requires the cannabi- 
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Me-AS-THC 5'.I.Me-AS.THC 
Fig. 1. Chemical structures of Me-ALTHC and 5'-I-Me-A8-THC. 
noid side-chain to assume an orientation parallel to the 
bilayer chains. Recently, the location of Me-AS-THC in the 
membrane was also studied using small angle X-ray 
diffraction. We found that this highly hydrophobic 
molecule distributes deeper in the bilayer away from the 
interface [8]. 
In the present study 5'-I-Me-AS-THC was used to deter- 
mine the location of the iodine atom in the bilayer and thus 
obtain information on the conformation of the alkyl chain. 
The analysis of the small angle X-ray diffraction results 
involved the determination of the signs of the structure 
factors using the swelling approach [9,10] and obtaining 
the electron density profile using a Fourier transform 
algorithm [11]. The electron density profiles were then 
placed on an absolute scale using the step-function model 
method [12-14]. The location of the drug molecules in the 
bilayer was obtained by comparing the electron density 
profiles of the hydrated DMPC preparations without and 
with the cannabinoids. Finally, DSC experiments were 
performed to study the mesomorphic phases of DMPC 
bilayers in the absence and presence of Me-AS-THC and 
its iodinated erivative. 
2. Materials and methods 
2.1. Materials 
Me-AS-THC and 5'-I-Me-AS-THC were synthesized in
our laboratory using methods reported elsewhere [15]. 
DMPC was obtained from Avanti Polar Lipids, Birming- 
ham, AL. 
2.2. Sample preparation 
DMPC alone or with the appropriate amount of 
cannabinoid (lipid to drug molar ratio 85:15, or x = 0.15) 
were dissolved in chloroform (99 + % pure, Aldrich, Mil- 
waukee, WI). The solvent was then removed using an 
Oz-free N 2 stream and the samples were dried under 
vacuum for 6 h. After adding distilled water, each sample 
was vortexed and sonicated in a water bath (50°C) for 15 
min until the suspension was translucent. For the X-ray 
diffraction experiments, the preparations were deposited on 
an aluminum foil, mounted on a curved glass and dried at 
35°C. This procedure took place in a chamber filled and 
continuously purged with nitrogen. For the DSC experi- 
ments, the vesicles were deposited on a glass surface, dried 
at 35°C and scraped into stainless teel DSC pans. Prior to 
the experiments, amples were suspended in closed vials 
with regulated relative humidities (RH) using appropriate 
saturated salt solutions for 24 h and 48 h, respectively. 
This produces partially hydrated multilamellar vesicles. 
The salts (Sigma, St. Louis, MO) used for the various 
relative humidities were LiC1 for RH 13%, NaNO 2 for RH 
66% and K2SO 4 for RH 98%. For the X-ray experiments, 
the preparations were transferred into RH-regulated con- 
tainers 3-5 h before the experiments. To keep the partial 
hydration of the DSC samples constant, the samples were 
sealed hermetically in stainless teel capsules. The partially 
hydrated samples prepared in this manner gave identical 
thermograms when tested repeatedly over a 7-day period. 
2.3. Differential scanning calorimetry 
Thermograms were obtained on a Perkin-Elmer DSC-7 
instrument and the temperature scale of the calorimeter 
was calibrated using fully hydrated DMPC and indium as 
standard samples. Prior to scanning the samples were held 
above their phase transition temperature for 1-2 min to 
ensure complete equilibration. All samples were then 
scanned at least twice until identical thermograms were 
obtained using a scanning rate of 1.5 C°/min. We found 
that samples gave the same thermograms if allowed to 
equilibrate for more than 48 h. 
2.4. X-ray diffraction 
X-ray diffraction experiments were carried out with an 
Elliot GXI8 rotating anode generator (Marconi Avionics), 
equipped with a camera utilizing a single vertical Franks' 
mirror [16]. Small angle X-ray diffraction patterns were 
collected using a Braun position sensitive proportional 
counting gas flow detector (Innovative Technology, New- 
buryport, MA). The sample temperature was kept constant 
with a Neslab 4B circulating water bath (Neslab Instru- 
ments, Newington, NH) and monitored with a thermister 
probe placed next to the canister. During the experiment, a 
helium path was used to reduce background scatter for a 
specimen-to-detector distance of 130 ram. The diffraction 
data were then collected with total accumulations of 1 - 10 6 
to 2 • 10 6 counts to improve the signal-to-noise ratio. Data 
was then transferred to a VAX computer system and the 
intensities were integrated directly from the computer plots 
by calculating the area under the diffraction peaks. 
3. Results and discussion 
3.1. Differential scanning calorimetry 
To ensure that comparisons were made between the 
membrane preparations atthe same mesomorphic state, the 
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phase properties were studied using DSC. Thermograms 
from DMPC preparations equilibrated at RH 98% without 
and with cannabinoid are shown in Fig. 2. The partially 
hydrated DMPC bilayer (top) shows a phase transition at 
29°C. The presence of the inactive cannabinoid Me-A 8- 
THC lowers only marginally the main phase transition 
temperature while it broadens it (middle) and a small 
pretransition peak appears at 15 ° C. Similar results were 
observed with the preparation containing 5'-I-Me-AS-THC 
(bottom). Thus, these results indicate that both Me-A8-THC 
and 5'-I-Me-ALTHC do not affect significantly the ther- 
motropic properties of DMPC bilayers. The fact that the 
pretransition was only observed in the preparations con- 
taining cannabinoid is not surprising. We are aware that 
this small transition preceding the main one is very sensi- 
tive to the water content as it is well known that fully 
hydrated DMPC bilayers show a pretransition. Therefore, 
we believe that its appearance only reflects the different 
water content between the preparations with and without 
the cannabinoid. 
3.2. Small angle X-ray diffraction 
Temperature d pendence of d-spacing 
The small angle X-ray diffraction patterns of the par- 
tially hydrated DMPC preparations consisted of six diffrac- 
tion orders when the temperature was below the phase 
transition and four diffraction orders when above the phase 
transition. The total period repeat distance (d-spacing) was 
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Fig. 2. Differential scanning calorimetry thermograms of partially hy- 
drated bilayers at RH 98%. DMPC alone (top), DMPC+Me-AS-THC 
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Fig. 3. d-spacing versus temperature for bilayer preparations of DMPC 
(circles and solid lines), DMPC + Me-AS-THC (x = 0.15, triangles and 
dotted lines) and DMPC + 5'-I-Me-AS-THC (x = 0.15, squares and dashed 
lines) equilibrated at RH 98%. 
derived from the diffraction patterns using Bragg's Law 
2dsin~9= hA; where 69 is the diffraction angle and h is 
the diffraction order. The d-spacing change versus temper- 
ature was studied to identify equivalent emperatures at
which appropriate comparisons could be made. At these 
temperatures, the drug-free and drug-containing DMPC 
preparations have similar d-spacings and are in the same 
mesomorphic phase. By comparing the data obtained at 
equivalent temperatures we then ensured that any electron 
density differences observed between preparations with 
and without he cannabinoid are solely due to the electron 
density contribution of the drug and not the different phase 
properties of the bilayers and/or any perturbation resulting 
from the presence of the cannabinoid. 
From the various relative humidities used in the experi- 
ments, the RH of 98% was chosen for our comparisons. 
Previous work had shown that optimal results are obtained 
when DMPC, DMPC + A8-THC and DMPC + Me-A 8- 
THC were compared under such conditions [8]. As can be 
seen in Fig. 3, preparations of DMPC, DMPC + Me-A 8- 
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Fig. 4. Comparison of electron density profiles of DMPC (solid line), 
DMPC +Me-AS-THC (short line) and DMPC + 5'-I-Me-AS-THC (long 
dashed line) at 36°C equilibrated at RH 98%. 
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Fig. 5. Electron density profile differences inside the bilayer: Curve B-A 
is the difference between profiles of DMPC + Me-AS-THC and DMPC. 
curve C-A is the difference between those of DMPC+5'-I-Me-/tS-THC 
and DMPC and curve C-B is the difference between those of DMPC 
+5'-[-Me-AS-THC and DMPC +Me-AS-THC. The vertical dashed lines 
indicate the peaks in curve C-B. They represent the positions of the center 
of AS-THC and the iodine atom of 5'-I-Me-AS-THC in the bilayer. 
crystalline phase (see also thermograms inoFig. 2) and have 
similar d-spacings of 50.84 A, 51.60 A and 50.59 ,~, 
respectively. On this basis, comparisons were made be- 
tween the electron density profiles of these three prepara- 
tions at the equivalent temperature of 36°C. 
Location of the cannabinoid in DMPC bilayers 
To compare the electron density profiles of bilayers 
with and without Me-A8-THC or 5'-I-Me-AS-THC we 
assumed that DMPC and the membrane containing 
cannabinoid preparations had identical electron densities at 
the level of the head groups and the terminal methyl 
groups [5]. On this basis, the profiles of the above three 
preparations were superimposed as shown in Fig. 4. 
Earlier solid state 2 H-NMR studies, had shown [7] that 
at x = 0.l 5 Me-AS-THC incorporates as readily as A~-THC 
into phospholipid bilayers. We, thus, expected Me-AS-THC 
to show a similar increase in the electron density profile as 
A~-THC (0,216 e/,~2). The ratio of the number of elec- 
trons of Me-A~-THC versus that of AS-THC (180/172) 
should be equal to the ratio of the increase in electron 
density (0.216 e/A~-). To fully account for such an in- 
crease in electron density due to the presence of Me-J  ~- 
THC in the DMPC bilayer, the trough of DMPC + Me-A ~- 
THC profile was adjusted to a position 0.015 e/,~ -~ above 
that of the DMPC while maintaining the same electron 
density at the head group. The long dashed line in Fig. 4 
shows the result of this superimposition. The same ratio- 
nale was used in the superimposition of 5'-I-Me-A~-THC 
whose total number of electrons is 232 and its electron 
density contribution is expected to be equal to 0.29 e/]~ 2 
(see Fig. 4). 
Fig. 5 shows the differences between the three profiles 
with an expanded scale. B-A represents the electron den- 
sity contribution due to Me-A8-THC in the DMPC bilayer. 
Its contribution has a maximum at the center of the bilayer 
and extends up to the interface with discernible shoulders 
at z = ± 10 A. This can be explained by assuming two 
preferred locations for Me-A~-THC, one at the center of 
the bilayer between the two membrane leaflets and a 
smaller portion residing between the contiguous lipid 
chains. The contribution due to the iodinated analog 5'-I- 
Me-A~-THC is depicted as C-A which shows an enhance- 
I l llLJlllll-- 
Latend diffusion of &8-THC in membrane blllyer 
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1111 ll.5 lllll 
Later~d diffusion of Me-& -STHc in membrane bilayer 
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Fig. 6. A proposed model for the molecular mechanism of action of JS-THC and Me-AS-THC. 
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ment in the region near the center of the bilayer. The net 
contribution due to the iodine atom can be obtained from 
the electron density difference between the Me-AIS-THC 
and 5'-I-Me-AIS-THC containing samples (C-B). There is 
an almost uniform increase from : = -5  A to z = 5 
indicating that the iodine atom does not occupy a specific 
location within the limits of resolution. Instead it has an 
ahnost equal prob~ability of being located in a region 
confined within 5 A from the center of the bilayer. 
4. Conclusions 
In this study, small angle X-ray diffraction and DSC 
were used to obtain information on the location and the 
thermotropic properties of Me-AS-THC and Y-I-Me-A s- 
THC in DMPC bilayers. The present X-ray diffraction 
experiments howed substantial incorporation of Me-A s- 
THC in the bilayer. We found that the electron density 
increase due to Me-AS-THC is distributed over a relatively 
wide region across the membrane bilayer near its center, 
This allowed us to draw the conclusion that the interaction 
of Me-3S-THC in the membrane bilayer is dictated exclu- 
sively by lipophilic considerations and that the molecule 
does not anchor itself at the polar interface of the bilayer 
as does the psychoactive AIS-THC [17]. Such interactions 
allow Me-AI~-THC to distribute itself within the inner core 
of the bilayer without being confined to a fixed location. 
The wide distribution of 5'-I-Me-AS-THC within the inner 
layer of the membrane is also evidenced by the enhance- 
ment in electron density due to the presence of the iodine 
within a 10 ,~ site from the center of the membrane 
bilayer. The X-ray diffraction results here are congruent 
with the solid state :H-NMR experiments where eH- 
labelled Me-AIS-THC was used in order to determine its 
preferred orientation in the bilayer. These results will be 
discussed in details elsewhere. 
It earlier work we showed that Me-AIS-THC does not 
increase the gauche:trans conformer ratio in DMPC bilay- 
ers as opposed to the known disordering effects produced 
by AIS-THC [7]. This supports reported DSC and solid state 
2 H-NMR data which showed that Me-AS-THC perturbs the 
membrane bilayer only marginally [3], This lack of mem- 
brane perturbing ability may be largely due to the fact that 
only a small fraction of Me-AS-THC can be accommo- 
dated between the acyl chains of the contiguous lipid 
molecules in the bilayer while the remaining Me-AS-THC 
residing in the center of the bilayer perturbs the membrane 
minimally. 
Cannabinoids are highly lipophilic [18-22] molecules 
and are known to produce their pharmacological effects by 
interacting with cellular membranes. These effects can thus 
be induced by one of the following two mechanisms [23]: 
(a) cannabinoids alter the conformational properties of 
lipids or other membrane components and thus alter mem- 
brane function; (b) cannabinoids may penetrate into the 
membrane, assume a suitable orientation and location, and 
then through lateral diffusion reach the specific site(s) of 
action on a membrane associated protein. The amphipathic 
interactions of these molecules with the membrane bilayers 
are accompanied by reduced chain cooperativity and in- 
duce significant membrane perturbation. AX-THC and other 
biologically active amphipathic cannabinoids localize near 
the membrane interface. Furthermore, they assume the 
proper location and orientation within the bilayer allowing 
them to reach the receptor through lateral diffusion and 
engage in a productive interaction with the active site (Fig. 
6. top). Conversely, the pharmacologically inactive Me- 
AS-THC fails to exert significant perturbation of the mem- 
brane bilayers. It may also assume an improper location 
and orientation in the membrane bilayer and is, thus, 
unable to productively interact with the receptor active site 
as shown in Fig. 6 (bottom). The above model [23] may 
provide a molecular interpretation of the differences in 
pharmacologically activity between the cannabinoids dis- 
cussed in this study. 
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